Amneal Pharmaceuticals Adds U.S. Manufacturing Jobs

Aug. 6, 2012
Generic drug maker's $120 million capital investment will add jobs in three states.

Amneal Pharmaceuticals LLC, a manufacturer of generic pharmaceuticals, announced on Monday that it is investing $120 million in physical plant capital expenditures at three of its six current U.S. R&D, manufacturing and distribution facilities during the next two years.

 Site expansions and infrastructure enhancement projects will create over 500 new jobs in manufacturing, research and development, distribution and sales at locations in New York, New Jersey and Kentucky.

The company now employs over 1,100 people in the United States.

"We clearly understand the value of, and are fully committed to, investing and growing within the market we serve, significantly expanding our number of 'Made in the USA' products," said Chirag Patel, Amneal president.

Driving further expansion in the U.S. market, Amneal said it is committed to spending 15-20% of annual revenue on R&D, while the industry norm is 5-6%.

Expanding stateside is an unusual move in the industry, the company noted, particularly in the New Jersey "pharma corridor," where several major branded drug companies have announced sizable layoffs this year.

The capital investment in its manufacturing plants and other facilities will support the firm's expansion into new products such as high potency medications, controlled substances and softgel capsules; new dosage forms including transdermal patches and injectables; and new therapeutic areas like oncology.

The generic pharmaceuticals segment has been a rare bright spot in pharma. This month the Generic Pharmaceutical Association reported that generic medicines now account for 80% of all prescriptions dispensed in the U.S. and have saved consumers and the U.S. healthcare system more than $1 trillion over the past ten years. 

About the Author

Adrienne Selko | Senior Editor

Focus: Workforce, Talent 

Follow Me on Twitter: @ASelkoIW

Bio: Adrienne Selko has written about many topics over the 17 years she has been with the publication and currently focuses on workforce development strategies. Previously Adrienne was in corporate communications at a medical manufacturing company as well as a large regional bank. She is the author of Do I Have to Wear Garlic Around My Neck? which made the Cleveland Plain Dealer's best sellers list. She is also a senior editor at Material Handling & Logistics and EHS Today

Editorial mission statement: Manufacturing is the enviable position of creating products, processes and policies that solve the world’s problems. When the industry stepped up to manufacture what was necessary to combat the pandemic, it revealed its true nature. My goal is to showcase the sector’s ability to address a broad range of workforce issues including technology, training, diversity & inclusion, with a goal of enticing future generations to join this amazing sector.

Why I find manufacturing interesting: On my first day working for a company that made medical equipment such as MRIs, I toured the plant floor. On every wall was a photo of a person, mostly children. I asked my supervisor why this was the case and he said that the work we do at this company has saved these people’s lives. “We never forget how important our work is and everyone’s contribution to that.” From that moment on I was hooked on manufacturing.

I have talked with many people in this field who have transformed their own career development to assist others. For example, companies are hiring those with disabilities, those previously incarcerated and other talent pools that have been underutilized. I have talked with leaders who have brought out the best in their workforce, as well as employees doing their best work while doing good for the world. 

Sponsored Recommendations

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!